Synta to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

<0> Synta Pharmaceuticals Corp.George Farmer, 781-541-7125 </0>

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Lazard Capital Markets 9 Annual Healthcare Conference on Wednesday, November 14 at 10:30 a.m. (EST) in New York.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, .

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit .

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.